As the U.S. imposes sweeping new tariffs on over 180 countries and territories—including a baseline 10% rate and steep increases for China (originally 145%, now reduced to 30% for 90 days) and Taiwan (32%, now reduced to 10%...more
At the recent ACC-Socal Double Header Event, Knobbe Martens presented, "CardiAQ - An IP Success Story."
...more
9/18/2018
/ Acquisitions ,
Assignment of Inventions ,
Breach of Contract ,
Damages ,
Enhanced Damages ,
Intellectual Property Protection ,
Inventors ,
Jury Trial ,
Jury Verdicts ,
Litigation Strategies ,
Medical Devices ,
Misappropriation ,
Non-Disclosure Agreement ,
Patent Applications ,
Post-Judgment Interest ,
Pre-Judgment Interest ,
Remedies ,
Trade Secrets
On September 1, the U.S. Court of Appeals for the Federal Circuit affirmed a $112 million win for Knobbe Martens client CardiAQ in its trade secret misappropriation case against former service provider Neovasc. A three-judge...more